Adacel® Vaccine Study
Participants needed: Men and women born in or after 1999 who received their childhood vaccines in Canada.
Pertussis (also called whooping cough) is a highly contagious severe disease that affects the airways of the nose, throat, and lungs, which causes long uncontrollable coughing spells. Whooping cough spreads very easily from person to person through coughing or sneezing. Vaccines for protection against whooping cough have been practiced for more than 60 years. Despite this, whooping cough is still a significant cause of serious illness in children and adults worldwide.
In this study we will collect a large blood sample prior to administering the licensed Adacel® (Tdap – tetanus, diphtheria and pertussis) vaccine and again at various times after you have received the vaccine. The sample will be used to assess certain markers in your blood and compare different tests and responses to the whooping cough vaccine. With the results, researchers hope to be able to evaluate new whooping cough vaccines or vaccine schedules.
Participation in this study consists of 5 visits over an approximate 4-6 week period. The total time commitment is about 1 ½ to 3 hours. Eligible participants will receive Adacel® (a licensed and recommended vaccine which protects against tetanus, diphtheria and whooping cough) and will be reimbursed for their travel/parking and time commitment.
If you’re interested in participating or hearing more about the study, please contact our Research Nurse Coordinator, Cathy Brown, at the number/email listed below.
Contact Cathy Brown